John Elflein is Statista's research expert for topics concerning health, diseases, and medical professionals in the United States and worldwide. In the past year he has written and published reports on topics such as the opioid epidemic, obesity, and mental health issues, and provided extensive coverage of the COVID-19 pandemic.
Research expert
John Elflein
Research expert covering health and health care
Latest publishings
State of Health COVID-19 death rates in the United States as of March 10, 2023, by state
Health, Pharma & Medtech Percentage of adults in the U.S. who smoke as of 2023, by state
Health, Pharma & Medtech Nonfatal occupational injuries and illness incident rate in the U.S. 2003-2023
State of Health Share of U.S. adults with diagnosed or undiagnosed diabetes 2021-2023
State of Health Share of adults in the U.S. reporting Long COVID symptoms as of 2024, by state
- State of HealthCoronavirus (COVID-19) disease pandemic- Statistics & Facts
- Health, Pharma & MedtechObesity in Canada - Statistics & Facts
- Health, Pharma & MedtechDisability in the U.S. - Statistics & Facts
- Health, Pharma & MedtechDeath in the United States - Statistics & Facts
- Health, Pharma & MedtechContraception in the U.S. - Statistics & Facts
statistics
- Death rates from COVID-19 in the United States as of March 10, 2023, by state (per 100,000 people)
- Percentage of adults who smoke in the United States as of 2023, by state
- Nonfatal occupational injuries and illness incident rate per 100 full-time equivalent workers in the United States from 2003 to 2023
- Percentage of adults in the United States with diagnosed or undiagnosed diabetes from 2021 to 2023
- Percentage of adults with Long COVID symptoms in the United States as of 2024, by state
Topics
About
John Elflein
Research expert covering health and health care
Our research department
Gain an in-depth understanding of our research methods and our guiding principles and learn more about our research department.
Customer support
Contact us anytime. We will respond to your inquiry as quickly as possible. Get in touch with us now.